nodes	percent_of_prediction	percent_of_DWPC	metapath
Zonisamide—SCN3A—spinal nerve—peripheral nervous system neoplasm	0.0172	0.0843	CbGeAlD
Zonisamide—CA10—ganglion—peripheral nervous system neoplasm	0.0123	0.0604	CbGeAlD
Zonisamide—SCN3B—ganglion—peripheral nervous system neoplasm	0.0119	0.0582	CbGeAlD
Zonisamide—CA13—nerve—peripheral nervous system neoplasm	0.0105	0.0513	CbGeAlD
Zonisamide—CA13—tongue—peripheral nervous system neoplasm	0.0102	0.0502	CbGeAlD
Zonisamide—SCN11A—nerve—peripheral nervous system neoplasm	0.00716	0.0351	CbGeAlD
Zonisamide—SCN11A—ganglion—peripheral nervous system neoplasm	0.00707	0.0347	CbGeAlD
Zonisamide—SCN2B—trigeminal ganglion—peripheral nervous system neoplasm	0.00698	0.0342	CbGeAlD
Zonisamide—CA10—trigeminal ganglion—peripheral nervous system neoplasm	0.00605	0.0297	CbGeAlD
Zonisamide—SCN3B—trigeminal ganglion—peripheral nervous system neoplasm	0.00582	0.0286	CbGeAlD
Zonisamide—CA10—brainstem—peripheral nervous system neoplasm	0.00535	0.0263	CbGeAlD
Zonisamide—CA8—brainstem—peripheral nervous system neoplasm	0.00525	0.0258	CbGeAlD
Zonisamide—SCN4B—trigeminal ganglion—peripheral nervous system neoplasm	0.00495	0.0243	CbGeAlD
Zonisamide—SCN4B—parotid gland—peripheral nervous system neoplasm	0.00467	0.0229	CbGeAlD
Zonisamide—CA13—brainstem—peripheral nervous system neoplasm	0.00449	0.022	CbGeAlD
Zonisamide—CA11—trigeminal ganglion—peripheral nervous system neoplasm	0.00426	0.0209	CbGeAlD
Zonisamide—CA11—brainstem—peripheral nervous system neoplasm	0.00377	0.0185	CbGeAlD
Zonisamide—SCN11A—trigeminal ganglion—peripheral nervous system neoplasm	0.00347	0.017	CbGeAlD
Zonisamide—SCN2B—cerebellum—peripheral nervous system neoplasm	0.00304	0.0149	CbGeAlD
Zonisamide—CA1—nerve—peripheral nervous system neoplasm	0.00301	0.0148	CbGeAlD
Zonisamide—SCN1B—cerebellum—peripheral nervous system neoplasm	0.00275	0.0135	CbGeAlD
Zonisamide—CA10—cerebellum—peripheral nervous system neoplasm	0.00264	0.0129	CbGeAlD
Zonisamide—CA6—parotid gland—peripheral nervous system neoplasm	0.00259	0.0127	CbGeAlD
Zonisamide—CA8—cerebellum—peripheral nervous system neoplasm	0.00259	0.0127	CbGeAlD
Zonisamide—SCN3B—cerebellum—peripheral nervous system neoplasm	0.00254	0.0125	CbGeAlD
Zonisamide—CA3—parotid gland—peripheral nervous system neoplasm	0.00245	0.012	CbGeAlD
Zonisamide—MAOB—nerve—peripheral nervous system neoplasm	0.00244	0.012	CbGeAlD
Zonisamide—MAOB—ganglion—peripheral nervous system neoplasm	0.00241	0.0118	CbGeAlD
Zonisamide—CA4—nerve—peripheral nervous system neoplasm	0.00235	0.0115	CbGeAlD
Zonisamide—CA4—ganglion—peripheral nervous system neoplasm	0.00232	0.0114	CbGeAlD
Zonisamide—SCN9A—trigeminal ganglion—peripheral nervous system neoplasm	0.00231	0.0114	CbGeAlD
Zonisamide—CA13—cerebellum—peripheral nervous system neoplasm	0.00221	0.0109	CbGeAlD
Zonisamide—SCN4B—cerebellum—peripheral nervous system neoplasm	0.00216	0.0106	CbGeAlD
Zonisamide—CACNA1I—cerebellum—peripheral nervous system neoplasm	0.00211	0.0104	CbGeAlD
Zonisamide—MAOA—nerve—peripheral nervous system neoplasm	0.00208	0.0102	CbGeAlD
Zonisamide—MAOA—ganglion—peripheral nervous system neoplasm	0.00206	0.0101	CbGeAlD
Zonisamide—CA11—cerebellum—peripheral nervous system neoplasm	0.00186	0.00912	CbGeAlD
Zonisamide—SCN1A—brainstem—peripheral nervous system neoplasm	0.00176	0.00864	CbGeAlD
Zonisamide—SCN2A—brainstem—peripheral nervous system neoplasm	0.00162	0.00793	CbGeAlD
Zonisamide—AOX1—trigeminal ganglion—peripheral nervous system neoplasm	0.00154	0.00754	CbGeAlD
Zonisamide—CACNA1G—cerebellum—peripheral nervous system neoplasm	0.00145	0.0071	CbGeAlD
Zonisamide—CA7—cerebellum—peripheral nervous system neoplasm	0.00124	0.00607	CbGeAlD
Zonisamide—MAOB—trigeminal ganglion—peripheral nervous system neoplasm	0.00118	0.00581	CbGeAlD
Zonisamide—MAOB—parotid gland—peripheral nervous system neoplasm	0.00112	0.00548	CbGeAlD
Zonisamide—CA9—cerebellum—peripheral nervous system neoplasm	0.00109	0.00533	CbGeAlD
Zonisamide—CA4—parotid gland—peripheral nervous system neoplasm	0.00108	0.00528	CbGeAlD
Zonisamide—MAOB—brainstem—peripheral nervous system neoplasm	0.00105	0.00514	CbGeAlD
Zonisamide—CA14—cerebellum—peripheral nervous system neoplasm	0.00103	0.00506	CbGeAlD
Zonisamide—MAOA—trigeminal ganglion—peripheral nervous system neoplasm	0.00101	0.00496	CbGeAlD
Zonisamide—CA4—brainstem—peripheral nervous system neoplasm	0.00101	0.00495	CbGeAlD
Zonisamide—MAOA—parotid gland—peripheral nervous system neoplasm	0.000953	0.00467	CbGeAlD
Zonisamide—CACNA1H—cerebellum—peripheral nervous system neoplasm	0.000946	0.00464	CbGeAlD
Zonisamide—CA2—trigeminal ganglion—peripheral nervous system neoplasm	0.000946	0.00464	CbGeAlD
Zonisamide—MAOA—brainstem—peripheral nervous system neoplasm	0.000894	0.00439	CbGeAlD
Zonisamide—CA2—parotid gland—peripheral nervous system neoplasm	0.000892	0.00438	CbGeAlD
Zonisamide—SCN1A—cerebellum—peripheral nervous system neoplasm	0.000868	0.00426	CbGeAlD
Zonisamide—CA2—brainstem—peripheral nervous system neoplasm	0.000837	0.00411	CbGeAlD
Zonisamide—SCN2A—cerebellum—peripheral nervous system neoplasm	0.000797	0.00391	CbGeAlD
Zonisamide—SCN3A—cerebellum—peripheral nervous system neoplasm	0.000701	0.00344	CbGeAlD
Zonisamide—AOX1—cerebellum—peripheral nervous system neoplasm	0.00067	0.00329	CbGeAlD
Zonisamide—MAOB—cerebellum—peripheral nervous system neoplasm	0.000517	0.00253	CbGeAlD
Zonisamide—CA4—cerebellum—peripheral nervous system neoplasm	0.000498	0.00244	CbGeAlD
Zonisamide—MAOA—cerebellum—peripheral nervous system neoplasm	0.000441	0.00216	CbGeAlD
Zonisamide—CA2—cerebellum—peripheral nervous system neoplasm	0.000413	0.00202	CbGeAlD
Zonisamide—Hypokalaemia—Doxorubicin—peripheral nervous system neoplasm	0.000219	0.000409	CcSEcCtD
Zonisamide—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000218	0.000406	CcSEcCtD
Zonisamide—Aspartate aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.000217	0.000404	CcSEcCtD
Zonisamide—Toxic epidermal necrolysis—Doxorubicin—peripheral nervous system neoplasm	0.000217	0.000404	CcSEcCtD
Zonisamide—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000217	0.000404	CcSEcCtD
Zonisamide—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000216	0.000402	CcSEcCtD
Zonisamide—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000215	0.000402	CcSEcCtD
Zonisamide—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000215	0.000401	CcSEcCtD
Zonisamide—Pancytopenia—Epirubicin—peripheral nervous system neoplasm	0.000214	0.000398	CcSEcCtD
Zonisamide—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000213	0.000398	CcSEcCtD
Zonisamide—Gastritis—Doxorubicin—peripheral nervous system neoplasm	0.000213	0.000398	CcSEcCtD
Zonisamide—Muscular weakness—Doxorubicin—peripheral nervous system neoplasm	0.000212	0.000396	CcSEcCtD
Zonisamide—Alanine aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.000212	0.000396	CcSEcCtD
Zonisamide—Dysuria—Epirubicin—peripheral nervous system neoplasm	0.00021	0.000392	CcSEcCtD
Zonisamide—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.00021	0.000391	CcSEcCtD
Zonisamide—Dysphagia—Doxorubicin—peripheral nervous system neoplasm	0.000208	0.000388	CcSEcCtD
Zonisamide—Influenza—Doxorubicin—peripheral nervous system neoplasm	0.000208	0.000388	CcSEcCtD
Zonisamide—Pollakiuria—Epirubicin—peripheral nervous system neoplasm	0.000208	0.000388	CcSEcCtD
Zonisamide—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000208	0.000387	CcSEcCtD
Zonisamide—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000207	0.000386	CcSEcCtD
Zonisamide—Eosinophilia—Doxorubicin—peripheral nervous system neoplasm	0.000206	0.000384	CcSEcCtD
Zonisamide—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000205	0.000383	CcSEcCtD
Zonisamide—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000205	0.000382	CcSEcCtD
Zonisamide—Weight increased—Epirubicin—peripheral nervous system neoplasm	0.000205	0.000382	CcSEcCtD
Zonisamide—Pancreatitis—Doxorubicin—peripheral nervous system neoplasm	0.000204	0.000381	CcSEcCtD
Zonisamide—Weight decreased—Epirubicin—peripheral nervous system neoplasm	0.000204	0.00038	CcSEcCtD
Zonisamide—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000203	0.000379	CcSEcCtD
Zonisamide—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000203	0.000378	CcSEcCtD
Zonisamide—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000202	0.000377	CcSEcCtD
Zonisamide—Pneumonia—Epirubicin—peripheral nervous system neoplasm	0.000202	0.000376	CcSEcCtD
Zonisamide—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.0002	0.000374	CcSEcCtD
Zonisamide—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.0002	0.000373	CcSEcCtD
Zonisamide—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	0.000199	0.000371	CcSEcCtD
Zonisamide—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000199	0.000371	CcSEcCtD
Zonisamide—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000198	0.00037	CcSEcCtD
Zonisamide—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000198	0.000369	CcSEcCtD
Zonisamide—Renal failure—Epirubicin—peripheral nervous system neoplasm	0.000197	0.000368	CcSEcCtD
Zonisamide—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000197	0.000367	CcSEcCtD
Zonisamide—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000197	0.000367	CcSEcCtD
Zonisamide—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000197	0.000367	CcSEcCtD
Zonisamide—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	0.000197	0.000367	CcSEcCtD
Zonisamide—Stomatitis—Epirubicin—peripheral nervous system neoplasm	0.000196	0.000365	CcSEcCtD
Zonisamide—Constipation—Etoposide—peripheral nervous system neoplasm	0.000195	0.000364	CcSEcCtD
Zonisamide—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	0.000195	0.000364	CcSEcCtD
Zonisamide—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	0.000195	0.000364	CcSEcCtD
Zonisamide—Dysuria—Doxorubicin—peripheral nervous system neoplasm	0.000195	0.000363	CcSEcCtD
Zonisamide—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000193	0.000361	CcSEcCtD
Zonisamide—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000193	0.00036	CcSEcCtD
Zonisamide—Sweating—Epirubicin—peripheral nervous system neoplasm	0.000192	0.000359	CcSEcCtD
Zonisamide—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	0.000192	0.000359	CcSEcCtD
Zonisamide—Haematuria—Epirubicin—peripheral nervous system neoplasm	0.000191	0.000357	CcSEcCtD
Zonisamide—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	0.00019	0.000354	CcSEcCtD
Zonisamide—Weight increased—Doxorubicin—peripheral nervous system neoplasm	0.000189	0.000353	CcSEcCtD
Zonisamide—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	0.000188	0.000351	CcSEcCtD
Zonisamide—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000188	0.000351	CcSEcCtD
Zonisamide—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000187	0.000349	CcSEcCtD
Zonisamide—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	0.000187	0.000349	CcSEcCtD
Zonisamide—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	0.000187	0.000348	CcSEcCtD
Zonisamide—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000187	0.000348	CcSEcCtD
Zonisamide—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000186	0.000347	CcSEcCtD
Zonisamide—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000186	0.000347	CcSEcCtD
Zonisamide—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000184	0.000344	CcSEcCtD
Zonisamide—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000184	0.000344	CcSEcCtD
Zonisamide—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	0.000184	0.000343	CcSEcCtD
Zonisamide—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000184	0.000342	CcSEcCtD
Zonisamide—Bradycardia—Epirubicin—peripheral nervous system neoplasm	0.000183	0.000342	CcSEcCtD
Zonisamide—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000183	0.000342	CcSEcCtD
Zonisamide—Renal failure—Doxorubicin—peripheral nervous system neoplasm	0.000182	0.00034	CcSEcCtD
Zonisamide—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000182	0.000339	CcSEcCtD
Zonisamide—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000181	0.000338	CcSEcCtD
Zonisamide—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	0.000181	0.000337	CcSEcCtD
Zonisamide—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.000181	0.000337	CcSEcCtD
Zonisamide—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.00018	0.000336	CcSEcCtD
Zonisamide—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.00018	0.000336	CcSEcCtD
Zonisamide—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	0.00018	0.000336	CcSEcCtD
Zonisamide—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	0.00018	0.000336	CcSEcCtD
Zonisamide—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000179	0.000334	CcSEcCtD
Zonisamide—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000179	0.000333	CcSEcCtD
Zonisamide—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000179	0.000333	CcSEcCtD
Zonisamide—Sweating—Doxorubicin—peripheral nervous system neoplasm	0.000178	0.000332	CcSEcCtD
Zonisamide—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.000178	0.000332	CcSEcCtD
Zonisamide—Rash—Vincristine—peripheral nervous system neoplasm	0.000178	0.000331	CcSEcCtD
Zonisamide—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000177	0.000331	CcSEcCtD
Zonisamide—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	0.000177	0.000331	CcSEcCtD
Zonisamide—Haematuria—Doxorubicin—peripheral nervous system neoplasm	0.000177	0.00033	CcSEcCtD
Zonisamide—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.000177	0.00033	CcSEcCtD
Zonisamide—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.000176	0.000329	CcSEcCtD
Zonisamide—Headache—Vincristine—peripheral nervous system neoplasm	0.000176	0.000329	CcSEcCtD
Zonisamide—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	0.000176	0.000327	CcSEcCtD
Zonisamide—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000174	0.000324	CcSEcCtD
Zonisamide—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	0.000173	0.000323	CcSEcCtD
Zonisamide—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.00017	0.000318	CcSEcCtD
Zonisamide—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	0.00017	0.000318	CcSEcCtD
Zonisamide—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	0.00017	0.000316	CcSEcCtD
Zonisamide—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.000168	0.000314	CcSEcCtD
Zonisamide—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000168	0.000314	CcSEcCtD
Zonisamide—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.000168	0.000313	CcSEcCtD
Zonisamide—Nausea—Vincristine—peripheral nervous system neoplasm	0.000167	0.000312	CcSEcCtD
Zonisamide—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	0.000167	0.000312	CcSEcCtD
Zonisamide—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000165	0.000308	CcSEcCtD
Zonisamide—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	0.000165	0.000307	CcSEcCtD
Zonisamide—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000164	0.000306	CcSEcCtD
Zonisamide—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000164	0.000305	CcSEcCtD
Zonisamide—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	0.000164	0.000305	CcSEcCtD
Zonisamide—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	0.000163	0.000305	CcSEcCtD
Zonisamide—SCN4A—Axon guidance—PTPN11—peripheral nervous system neoplasm	0.000163	0.000626	CbGpPWpGaD
Zonisamide—SCN2A—Axon guidance—PTPN11—peripheral nervous system neoplasm	0.000163	0.000626	CbGpPWpGaD
Zonisamide—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.000163	0.000303	CcSEcCtD
Zonisamide—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000162	0.000303	CcSEcCtD
Zonisamide—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000161	0.000301	CcSEcCtD
Zonisamide—Alopecia—Epirubicin—peripheral nervous system neoplasm	0.000159	0.000297	CcSEcCtD
Zonisamide—CA4—Metabolism—COX2—peripheral nervous system neoplasm	0.000159	0.00061	CbGpPWpGaD
Zonisamide—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000158	0.000295	CcSEcCtD
Zonisamide—SCN4B—Developmental Biology—HRAS—peripheral nervous system neoplasm	0.000158	0.000608	CbGpPWpGaD
Zonisamide—CA1—Metabolism—GNS—peripheral nervous system neoplasm	0.000158	0.000607	CbGpPWpGaD
Zonisamide—CA2—Metabolism—NME1—peripheral nervous system neoplasm	0.000158	0.000607	CbGpPWpGaD
Zonisamide—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000158	0.000294	CcSEcCtD
Zonisamide—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	0.000158	0.000294	CcSEcCtD
Zonisamide—Rash—Cisplatin—peripheral nervous system neoplasm	0.000157	0.000293	CcSEcCtD
Zonisamide—SCN1A—Axon guidance—PTPN11—peripheral nervous system neoplasm	0.000157	0.000604	CbGpPWpGaD
Zonisamide—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000157	0.000293	CcSEcCtD
Zonisamide—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.000157	0.000292	CcSEcCtD
Zonisamide—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000156	0.000291	CcSEcCtD
Zonisamide—CA3—Metabolism—GNAS—peripheral nervous system neoplasm	0.000156	0.000599	CbGpPWpGaD
Zonisamide—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.000156	0.00029	CcSEcCtD
Zonisamide—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.000155	0.00029	CcSEcCtD
Zonisamide—AOX1—Metabolism—GNS—peripheral nervous system neoplasm	0.000155	0.000595	CbGpPWpGaD
Zonisamide—CA14—Metabolism—ENO2—peripheral nervous system neoplasm	0.000155	0.000595	CbGpPWpGaD
Zonisamide—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.000154	0.000288	CcSEcCtD
Zonisamide—Tension—Epirubicin—peripheral nervous system neoplasm	0.000154	0.000287	CcSEcCtD
Zonisamide—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000153	0.000286	CcSEcCtD
Zonisamide—CA3—Metabolism—ABCB1—peripheral nervous system neoplasm	0.000153	0.000588	CbGpPWpGaD
Zonisamide—SCN1B—Developmental Biology—AKT1—peripheral nervous system neoplasm	0.000153	0.000587	CbGpPWpGaD
Zonisamide—SCN2B—Developmental Biology—AKT1—peripheral nervous system neoplasm	0.000153	0.000587	CbGpPWpGaD
Zonisamide—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000152	0.000284	CcSEcCtD
Zonisamide—CA2—Metabolism—COX2—peripheral nervous system neoplasm	0.000152	0.000584	CbGpPWpGaD
Zonisamide—CACNA1I—Axon guidance—NRAS—peripheral nervous system neoplasm	0.000152	0.000584	CbGpPWpGaD
Zonisamide—CA1—Metabolism—NME1—peripheral nervous system neoplasm	0.000151	0.000582	CbGpPWpGaD
Zonisamide—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000151	0.000281	CcSEcCtD
Zonisamide—CA5A—Metabolism—ENO2—peripheral nervous system neoplasm	0.000151	0.00058	CbGpPWpGaD
Zonisamide—CA6—Metabolism—ENO2—peripheral nervous system neoplasm	0.000151	0.00058	CbGpPWpGaD
Zonisamide—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000151	0.000281	CcSEcCtD
Zonisamide—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.00015	0.000281	CcSEcCtD
Zonisamide—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.00015	0.00028	CcSEcCtD
Zonisamide—AOX1—Metabolism—NME1—peripheral nervous system neoplasm	0.000148	0.000571	CbGpPWpGaD
Zonisamide—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000148	0.000276	CcSEcCtD
Zonisamide—CACNA1G—Axon guidance—ERBB2—peripheral nervous system neoplasm	0.000147	0.000566	CbGpPWpGaD
Zonisamide—Alopecia—Doxorubicin—peripheral nervous system neoplasm	0.000147	0.000275	CcSEcCtD
Zonisamide—SCN3B—Developmental Biology—HRAS—peripheral nervous system neoplasm	0.000147	0.000565	CbGpPWpGaD
Zonisamide—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000146	0.000272	CcSEcCtD
Zonisamide—CA1—Metabolism—COX2—peripheral nervous system neoplasm	0.000146	0.00056	CbGpPWpGaD
Zonisamide—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000145	0.000271	CcSEcCtD
Zonisamide—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000145	0.000271	CcSEcCtD
Zonisamide—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.000145	0.000271	CcSEcCtD
Zonisamide—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.000145	0.00027	CcSEcCtD
Zonisamide—SCN11A—Axon guidance—NRAS—peripheral nervous system neoplasm	0.000144	0.000554	CbGpPWpGaD
Zonisamide—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000144	0.000269	CcSEcCtD
Zonisamide—Rash—Etoposide—peripheral nervous system neoplasm	0.000144	0.000268	CcSEcCtD
Zonisamide—CACNA1G—Developmental Biology—MET—peripheral nervous system neoplasm	0.000144	0.000553	CbGpPWpGaD
Zonisamide—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000144	0.000268	CcSEcCtD
Zonisamide—Headache—Etoposide—peripheral nervous system neoplasm	0.000143	0.000267	CcSEcCtD
Zonisamide—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.000143	0.000267	CcSEcCtD
Zonisamide—AOX1—Metabolism—COX2—peripheral nervous system neoplasm	0.000143	0.000549	CbGpPWpGaD
Zonisamide—CACNA1H—Axon guidance—ERBB2—peripheral nervous system neoplasm	0.000143	0.000548	CbGpPWpGaD
Zonisamide—CACNA1I—Developmental Biology—ERBB2—peripheral nervous system neoplasm	0.000143	0.000548	CbGpPWpGaD
Zonisamide—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000142	0.000265	CcSEcCtD
Zonisamide—SCN5A—SIDS Susceptibility Pathways—CASP3—peripheral nervous system neoplasm	0.000142	0.000547	CbGpPWpGaD
Zonisamide—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000142	0.000265	CcSEcCtD
Zonisamide—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000141	0.000264	CcSEcCtD
Zonisamide—CA5B—Metabolism—ENO2—peripheral nervous system neoplasm	0.000141	0.000542	CbGpPWpGaD
Zonisamide—CA7—Metabolism—ENO2—peripheral nervous system neoplasm	0.000141	0.000542	CbGpPWpGaD
Zonisamide—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000141	0.000263	CcSEcCtD
Zonisamide—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000141	0.000263	CcSEcCtD
Zonisamide—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000141	0.000262	CcSEcCtD
Zonisamide—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.00014	0.000262	CcSEcCtD
Zonisamide—SCN9A—Axon guidance—ERBB2—peripheral nervous system neoplasm	0.00014	0.000539	CbGpPWpGaD
Zonisamide—SCN4B—Developmental Biology—AKT1—peripheral nervous system neoplasm	0.00014	0.000537	CbGpPWpGaD
Zonisamide—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.000139	0.00026	CcSEcCtD
Zonisamide—CACNA1H—Developmental Biology—MET—peripheral nervous system neoplasm	0.000139	0.000535	CbGpPWpGaD
Zonisamide—CA9—Metabolism—GNS—peripheral nervous system neoplasm	0.000139	0.000534	CbGpPWpGaD
Zonisamide—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000139	0.000258	CcSEcCtD
Zonisamide—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000138	0.000257	CcSEcCtD
Zonisamide—Cough—Epirubicin—peripheral nervous system neoplasm	0.000137	0.000255	CcSEcCtD
Zonisamide—SCN9A—Developmental Biology—MET—peripheral nervous system neoplasm	0.000137	0.000526	CbGpPWpGaD
Zonisamide—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000136	0.000253	CcSEcCtD
Zonisamide—Nausea—Etoposide—peripheral nervous system neoplasm	0.000136	0.000253	CcSEcCtD
Zonisamide—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000135	0.000252	CcSEcCtD
Zonisamide—SCN11A—Developmental Biology—ERBB2—peripheral nervous system neoplasm	0.000135	0.00052	CbGpPWpGaD
Zonisamide—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000135	0.000251	CcSEcCtD
Zonisamide—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000134	0.00025	CcSEcCtD
Zonisamide—SCN3A—Axon guidance—ERBB2—peripheral nervous system neoplasm	0.000134	0.000515	CbGpPWpGaD
Zonisamide—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000133	0.000249	CcSEcCtD
Zonisamide—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000133	0.000249	CcSEcCtD
Zonisamide—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000133	0.000249	CcSEcCtD
Zonisamide—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000133	0.000249	CcSEcCtD
Zonisamide—CA9—Metabolism—NME1—peripheral nervous system neoplasm	0.000133	0.000512	CbGpPWpGaD
Zonisamide—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000133	0.000248	CcSEcCtD
Zonisamide—CACNA1G—Developmental Biology—PTPN11—peripheral nervous system neoplasm	0.000133	0.000511	CbGpPWpGaD
Zonisamide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000133	0.000247	CcSEcCtD
Zonisamide—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000132	0.000246	CcSEcCtD
Zonisamide—MAOB—Metabolism—GNS—peripheral nervous system neoplasm	0.000131	0.000503	CbGpPWpGaD
Zonisamide—CA14—Metabolism—BCHE—peripheral nervous system neoplasm	0.000131	0.000503	CbGpPWpGaD
Zonisamide—SCN3A—Developmental Biology—MET—peripheral nervous system neoplasm	0.000131	0.000503	CbGpPWpGaD
Zonisamide—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000131	0.000244	CcSEcCtD
Zonisamide—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000131	0.000243	CcSEcCtD
Zonisamide—CA12—Metabolism—ENO2—peripheral nervous system neoplasm	0.000131	0.000502	CbGpPWpGaD
Zonisamide—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.00013	0.000243	CcSEcCtD
Zonisamide—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.00013	0.000243	CcSEcCtD
Zonisamide—CA9—Cellular responses to stress—CDKN2A—peripheral nervous system neoplasm	0.00013	0.0005	CbGpPWpGaD
Zonisamide—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.00013	0.000242	CcSEcCtD
Zonisamide—SCN3B—Developmental Biology—AKT1—peripheral nervous system neoplasm	0.00013	0.000499	CbGpPWpGaD
Zonisamide—AOX1—Disease—PPP3R1—peripheral nervous system neoplasm	0.000129	0.000497	CbGpPWpGaD
Zonisamide—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000129	0.000241	CcSEcCtD
Zonisamide—CACNA1H—Developmental Biology—PTPN11—peripheral nervous system neoplasm	0.000129	0.000495	CbGpPWpGaD
Zonisamide—SCN2A—Axon guidance—ERBB2—peripheral nervous system neoplasm	0.000129	0.000495	CbGpPWpGaD
Zonisamide—SCN4A—Axon guidance—ERBB2—peripheral nervous system neoplasm	0.000129	0.000495	CbGpPWpGaD
Zonisamide—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000128	0.000239	CcSEcCtD
Zonisamide—CA9—Metabolism—COX2—peripheral nervous system neoplasm	0.000128	0.000493	CbGpPWpGaD
Zonisamide—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000128	0.000239	CcSEcCtD
Zonisamide—CA5A—Metabolism—BCHE—peripheral nervous system neoplasm	0.000127	0.00049	CbGpPWpGaD
Zonisamide—CA6—Metabolism—BCHE—peripheral nervous system neoplasm	0.000127	0.00049	CbGpPWpGaD
Zonisamide—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000127	0.000238	CcSEcCtD
Zonisamide—Infection—Epirubicin—peripheral nervous system neoplasm	0.000127	0.000237	CcSEcCtD
Zonisamide—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000127	0.000236	CcSEcCtD
Zonisamide—SCN9A—Developmental Biology—PTPN11—peripheral nervous system neoplasm	0.000126	0.000486	CbGpPWpGaD
Zonisamide—Shock—Epirubicin—peripheral nervous system neoplasm	0.000126	0.000235	CcSEcCtD
Zonisamide—SCN2A—Developmental Biology—MET—peripheral nervous system neoplasm	0.000126	0.000483	CbGpPWpGaD
Zonisamide—SCN4A—Developmental Biology—MET—peripheral nervous system neoplasm	0.000126	0.000483	CbGpPWpGaD
Zonisamide—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000126	0.000234	CcSEcCtD
Zonisamide—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000125	0.000234	CcSEcCtD
Zonisamide—MAOB—Metabolism—NME1—peripheral nervous system neoplasm	0.000125	0.000482	CbGpPWpGaD
Zonisamide—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000125	0.000234	CcSEcCtD
Zonisamide—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000125	0.000234	CcSEcCtD
Zonisamide—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000125	0.000233	CcSEcCtD
Zonisamide—CA14—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000125	0.00048	CbGpPWpGaD
Zonisamide—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000124	0.000232	CcSEcCtD
Zonisamide—SCN1A—Axon guidance—ERBB2—peripheral nervous system neoplasm	0.000124	0.000477	CbGpPWpGaD
Zonisamide—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000124	0.000231	CcSEcCtD
Zonisamide—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000123	0.00023	CcSEcCtD
Zonisamide—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000123	0.00023	CcSEcCtD
Zonisamide—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000123	0.00023	CcSEcCtD
Zonisamide—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000123	0.00023	CcSEcCtD
Zonisamide—CA14—Metabolism—TH—peripheral nervous system neoplasm	0.000123	0.000473	CbGpPWpGaD
Zonisamide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000123	0.000229	CcSEcCtD
Zonisamide—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000122	0.000228	CcSEcCtD
Zonisamide—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000122	0.000227	CcSEcCtD
Zonisamide—CA6—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000122	0.000468	CbGpPWpGaD
Zonisamide—CA5A—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000122	0.000468	CbGpPWpGaD
Zonisamide—SCN1A—Developmental Biology—MET—peripheral nervous system neoplasm	0.000121	0.000466	CbGpPWpGaD
Zonisamide—SCN3A—Developmental Biology—PTPN11—peripheral nervous system neoplasm	0.000121	0.000465	CbGpPWpGaD
Zonisamide—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000121	0.000225	CcSEcCtD
Zonisamide—MAOB—Metabolism—COX2—peripheral nervous system neoplasm	0.000121	0.000464	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.000121	0.000464	CbGpPWpGaD
Zonisamide—CA5A—Metabolism—TH—peripheral nervous system neoplasm	0.00012	0.000461	CbGpPWpGaD
Zonisamide—CA6—Metabolism—TH—peripheral nervous system neoplasm	0.00012	0.000461	CbGpPWpGaD
Zonisamide—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.00012	0.000223	CcSEcCtD
Zonisamide—SCN5A—Axon guidance—MET—peripheral nervous system neoplasm	0.000119	0.000459	CbGpPWpGaD
Zonisamide—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000119	0.000223	CcSEcCtD
Zonisamide—CA5B—Metabolism—BCHE—peripheral nervous system neoplasm	0.000119	0.000458	CbGpPWpGaD
Zonisamide—CA7—Metabolism—BCHE—peripheral nervous system neoplasm	0.000119	0.000458	CbGpPWpGaD
Zonisamide—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000118	0.000221	CcSEcCtD
Zonisamide—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000118	0.000219	CcSEcCtD
Zonisamide—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000117	0.000217	CcSEcCtD
Zonisamide—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000116	0.000217	CcSEcCtD
Zonisamide—SCN4A—Developmental Biology—PTPN11—peripheral nervous system neoplasm	0.000116	0.000447	CbGpPWpGaD
Zonisamide—SCN2A—Developmental Biology—PTPN11—peripheral nervous system neoplasm	0.000116	0.000447	CbGpPWpGaD
Zonisamide—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000116	0.000217	CcSEcCtD
Zonisamide—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000116	0.000216	CcSEcCtD
Zonisamide—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000116	0.000216	CcSEcCtD
Zonisamide—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000116	0.000215	CcSEcCtD
Zonisamide—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000115	0.000214	CcSEcCtD
Zonisamide—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000115	0.000214	CcSEcCtD
Zonisamide—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000114	0.000213	CcSEcCtD
Zonisamide—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000114	0.000213	CcSEcCtD
Zonisamide—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000114	0.000212	CcSEcCtD
Zonisamide—CA5B—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000114	0.000437	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000114	0.000437	CbGpPWpGaD
Zonisamide—CA7—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000114	0.000437	CbGpPWpGaD
Zonisamide—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000113	0.00021	CcSEcCtD
Zonisamide—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000113	0.00021	CcSEcCtD
Zonisamide—SCN1A—Developmental Biology—PTPN11—peripheral nervous system neoplasm	0.000112	0.000431	CbGpPWpGaD
Zonisamide—CACNA1G—Axon guidance—NRAS—peripheral nervous system neoplasm	0.000112	0.000431	CbGpPWpGaD
Zonisamide—AOX1—Disease—ENO2—peripheral nervous system neoplasm	0.000112	0.000431	CbGpPWpGaD
Zonisamide—CA7—Metabolism—TH—peripheral nervous system neoplasm	0.000112	0.00043	CbGpPWpGaD
Zonisamide—CA5B—Metabolism—TH—peripheral nervous system neoplasm	0.000112	0.00043	CbGpPWpGaD
Zonisamide—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000111	0.000207	CcSEcCtD
Zonisamide—CACNA1I—Axon guidance—HRAS—peripheral nervous system neoplasm	0.000111	0.000428	CbGpPWpGaD
Zonisamide—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000111	0.000206	CcSEcCtD
Zonisamide—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.00011	0.000206	CcSEcCtD
Zonisamide—SCN5A—Axon guidance—PTPN11—peripheral nervous system neoplasm	0.00011	0.000425	CbGpPWpGaD
Zonisamide—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.00011	0.000206	CcSEcCtD
Zonisamide—CA12—Metabolism—BCHE—peripheral nervous system neoplasm	0.00011	0.000424	CbGpPWpGaD
Zonisamide—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000109	0.000204	CcSEcCtD
Zonisamide—CACNA1H—Axon guidance—NRAS—peripheral nervous system neoplasm	0.000109	0.000417	CbGpPWpGaD
Zonisamide—CACNA1I—Developmental Biology—NRAS—peripheral nervous system neoplasm	0.000108	0.000417	CbGpPWpGaD
Zonisamide—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000108	0.000201	CcSEcCtD
Zonisamide—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000107	0.0002	CcSEcCtD
Zonisamide—SCN9A—Axon guidance—NRAS—peripheral nervous system neoplasm	0.000107	0.00041	CbGpPWpGaD
Zonisamide—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000106	0.000198	CcSEcCtD
Zonisamide—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000106	0.000197	CcSEcCtD
Zonisamide—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000105	0.000197	CcSEcCtD
Zonisamide—SCN11A—Axon guidance—HRAS—peripheral nervous system neoplasm	0.000105	0.000405	CbGpPWpGaD
Zonisamide—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000105	0.000196	CcSEcCtD
Zonisamide—CA12—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000105	0.000404	CbGpPWpGaD
Zonisamide—CACNA1G—Developmental Biology—ERBB2—peripheral nervous system neoplasm	0.000105	0.000404	CbGpPWpGaD
Zonisamide—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000105	0.000195	CcSEcCtD
Zonisamide—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000104	0.000194	CcSEcCtD
Zonisamide—CA4—Metabolism—ENO2—peripheral nervous system neoplasm	0.000104	0.0004	CbGpPWpGaD
Zonisamide—CA12—Metabolism—TH—peripheral nervous system neoplasm	0.000104	0.000399	CbGpPWpGaD
Zonisamide—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000103	0.000192	CcSEcCtD
Zonisamide—SCN11A—Developmental Biology—NRAS—peripheral nervous system neoplasm	0.000103	0.000395	CbGpPWpGaD
Zonisamide—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000102	0.000191	CcSEcCtD
Zonisamide—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000102	0.00019	CcSEcCtD
Zonisamide—SCN3A—Axon guidance—NRAS—peripheral nervous system neoplasm	0.000102	0.000392	CbGpPWpGaD
Zonisamide—CACNA1H—Developmental Biology—ERBB2—peripheral nervous system neoplasm	0.000102	0.000391	CbGpPWpGaD
Zonisamide—MAOA—SIDS Susceptibility Pathways—CASP3—peripheral nervous system neoplasm	0.000102	0.000391	CbGpPWpGaD
Zonisamide—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000102	0.00019	CcSEcCtD
Zonisamide—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000101	0.000189	CcSEcCtD
Zonisamide—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000101	0.000189	CcSEcCtD
Zonisamide—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000101	0.000189	CcSEcCtD
Zonisamide—CA14—Metabolism—GNAS—peripheral nervous system neoplasm	0.0001	0.000386	CbGpPWpGaD
Zonisamide—SCN9A—Developmental Biology—ERBB2—peripheral nervous system neoplasm	0.0001	0.000384	CbGpPWpGaD
Zonisamide—CA2—Metabolism—ENO2—peripheral nervous system neoplasm	9.98e-05	0.000384	CbGpPWpGaD
Zonisamide—CA14—Metabolism—ABCB1—peripheral nervous system neoplasm	9.85e-05	0.000379	CbGpPWpGaD
Zonisamide—SCN4A—Axon guidance—NRAS—peripheral nervous system neoplasm	9.79e-05	0.000377	CbGpPWpGaD
Zonisamide—SCN2A—Axon guidance—NRAS—peripheral nervous system neoplasm	9.79e-05	0.000377	CbGpPWpGaD
Zonisamide—CA6—Metabolism—GNAS—peripheral nervous system neoplasm	9.79e-05	0.000376	CbGpPWpGaD
Zonisamide—CA5A—Metabolism—GNAS—peripheral nervous system neoplasm	9.79e-05	0.000376	CbGpPWpGaD
Zonisamide—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	9.75e-05	0.000182	CcSEcCtD
Zonisamide—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	9.68e-05	0.000181	CcSEcCtD
Zonisamide—CA5A—Metabolism—ABCB1—peripheral nervous system neoplasm	9.6e-05	0.000369	CbGpPWpGaD
Zonisamide—CA6—Metabolism—ABCB1—peripheral nervous system neoplasm	9.6e-05	0.000369	CbGpPWpGaD
Zonisamide—CA1—Metabolism—ENO2—peripheral nervous system neoplasm	9.57e-05	0.000368	CbGpPWpGaD
Zonisamide—SCN3A—Developmental Biology—ERBB2—peripheral nervous system neoplasm	9.56e-05	0.000368	CbGpPWpGaD
Zonisamide—SCN1A—Axon guidance—NRAS—peripheral nervous system neoplasm	9.44e-05	0.000363	CbGpPWpGaD
Zonisamide—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	9.42e-05	0.000176	CcSEcCtD
Zonisamide—Urticaria—Doxorubicin—peripheral nervous system neoplasm	9.4e-05	0.000175	CcSEcCtD
Zonisamide—AOX1—Metabolism—ENO2—peripheral nervous system neoplasm	9.38e-05	0.000361	CbGpPWpGaD
Zonisamide—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	9.36e-05	0.000175	CcSEcCtD
Zonisamide—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	9.36e-05	0.000175	CcSEcCtD
Zonisamide—SCN2A—Developmental Biology—ERBB2—peripheral nervous system neoplasm	9.19e-05	0.000353	CbGpPWpGaD
Zonisamide—SCN4A—Developmental Biology—ERBB2—peripheral nervous system neoplasm	9.19e-05	0.000353	CbGpPWpGaD
Zonisamide—Asthenia—Epirubicin—peripheral nervous system neoplasm	9.18e-05	0.000171	CcSEcCtD
Zonisamide—CA7—Metabolism—GNAS—peripheral nervous system neoplasm	9.14e-05	0.000351	CbGpPWpGaD
Zonisamide—CA5B—Metabolism—GNAS—peripheral nervous system neoplasm	9.14e-05	0.000351	CbGpPWpGaD
Zonisamide—Pruritus—Epirubicin—peripheral nervous system neoplasm	9.05e-05	0.000169	CcSEcCtD
Zonisamide—AOX1—Disease—SLC2A1—peripheral nervous system neoplasm	9.03e-05	0.000347	CbGpPWpGaD
Zonisamide—CA5B—Metabolism—ABCB1—peripheral nervous system neoplasm	8.96e-05	0.000345	CbGpPWpGaD
Zonisamide—CA7—Metabolism—ABCB1—peripheral nervous system neoplasm	8.96e-05	0.000345	CbGpPWpGaD
Zonisamide—SCN1A—Developmental Biology—ERBB2—peripheral nervous system neoplasm	8.86e-05	0.000341	CbGpPWpGaD
Zonisamide—CA4—Metabolism—BCHE—peripheral nervous system neoplasm	8.79e-05	0.000338	CbGpPWpGaD
Zonisamide—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	8.75e-05	0.000163	CcSEcCtD
Zonisamide—SCN5A—Axon guidance—ERBB2—peripheral nervous system neoplasm	8.73e-05	0.000336	CbGpPWpGaD
Zonisamide—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	8.72e-05	0.000163	CcSEcCtD
Zonisamide—SCN5A—Developmental Biology—MET—peripheral nervous system neoplasm	8.52e-05	0.000328	CbGpPWpGaD
Zonisamide—Asthenia—Doxorubicin—peripheral nervous system neoplasm	8.49e-05	0.000158	CcSEcCtD
Zonisamide—CA12—Metabolism—GNAS—peripheral nervous system neoplasm	8.46e-05	0.000325	CbGpPWpGaD
Zonisamide—Dizziness—Epirubicin—peripheral nervous system neoplasm	8.46e-05	0.000158	CcSEcCtD
Zonisamide—CA2—Metabolism—BCHE—peripheral nervous system neoplasm	8.43e-05	0.000324	CbGpPWpGaD
Zonisamide—CA9—Metabolism—ENO2—peripheral nervous system neoplasm	8.41e-05	0.000323	CbGpPWpGaD
Zonisamide—CA4—Metabolism—SLC2A1—peripheral nervous system neoplasm	8.39e-05	0.000323	CbGpPWpGaD
Zonisamide—Pruritus—Doxorubicin—peripheral nervous system neoplasm	8.37e-05	0.000156	CcSEcCtD
Zonisamide—CA12—Metabolism—ABCB1—peripheral nervous system neoplasm	8.31e-05	0.000319	CbGpPWpGaD
Zonisamide—CA4—Metabolism—TH—peripheral nervous system neoplasm	8.27e-05	0.000318	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—GNS—peripheral nervous system neoplasm	8.21e-05	0.000316	CbGpPWpGaD
Zonisamide—CACNA1G—Axon guidance—HRAS—peripheral nervous system neoplasm	8.2e-05	0.000315	CbGpPWpGaD
Zonisamide—Vomiting—Epirubicin—peripheral nervous system neoplasm	8.13e-05	0.000152	CcSEcCtD
Zonisamide—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	8.1e-05	0.000151	CcSEcCtD
Zonisamide—CA1—Metabolism—BCHE—peripheral nervous system neoplasm	8.08e-05	0.000311	CbGpPWpGaD
Zonisamide—Rash—Epirubicin—peripheral nervous system neoplasm	8.07e-05	0.00015	CcSEcCtD
Zonisamide—Dermatitis—Epirubicin—peripheral nervous system neoplasm	8.06e-05	0.00015	CcSEcCtD
Zonisamide—CA2—Metabolism—SLC2A1—peripheral nervous system neoplasm	8.04e-05	0.000309	CbGpPWpGaD
Zonisamide—Headache—Epirubicin—peripheral nervous system neoplasm	8.01e-05	0.000149	CcSEcCtD
Zonisamide—CA13—Metabolism—AKT1—peripheral nervous system neoplasm	8.01e-05	0.000308	CbGpPWpGaD
Zonisamide—CACNA1G—Developmental Biology—NRAS—peripheral nervous system neoplasm	8e-05	0.000307	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—PPIP5K2—peripheral nervous system neoplasm	7.96e-05	0.000306	CbGpPWpGaD
Zonisamide—CACNA1H—Axon guidance—HRAS—peripheral nervous system neoplasm	7.94e-05	0.000305	CbGpPWpGaD
Zonisamide—CACNA1I—Developmental Biology—HRAS—peripheral nervous system neoplasm	7.93e-05	0.000305	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—ENO2—peripheral nervous system neoplasm	7.93e-05	0.000305	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—BCHE—peripheral nervous system neoplasm	7.93e-05	0.000305	CbGpPWpGaD
Zonisamide—CA2—Metabolism—TH—peripheral nervous system neoplasm	7.93e-05	0.000305	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—PTPN11—peripheral nervous system neoplasm	7.88e-05	0.000303	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—NME1—peripheral nervous system neoplasm	7.87e-05	0.000303	CbGpPWpGaD
Zonisamide—Dizziness—Doxorubicin—peripheral nervous system neoplasm	7.83e-05	0.000146	CcSEcCtD
Zonisamide—SCN9A—Axon guidance—HRAS—peripheral nervous system neoplasm	7.8e-05	0.0003	CbGpPWpGaD
Zonisamide—CACNA1H—Developmental Biology—NRAS—peripheral nervous system neoplasm	7.74e-05	0.000298	CbGpPWpGaD
Zonisamide—CA1—Metabolism—SLC2A1—peripheral nervous system neoplasm	7.71e-05	0.000296	CbGpPWpGaD
Zonisamide—SCN9A—Developmental Biology—NRAS—peripheral nervous system neoplasm	7.6e-05	0.000292	CbGpPWpGaD
Zonisamide—CA1—Metabolism—TH—peripheral nervous system neoplasm	7.6e-05	0.000292	CbGpPWpGaD
Zonisamide—Nausea—Epirubicin—peripheral nervous system neoplasm	7.6e-05	0.000142	CcSEcCtD
Zonisamide—MAOA—Metabolism—COX2—peripheral nervous system neoplasm	7.58e-05	0.000291	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—SLC2A1—peripheral nervous system neoplasm	7.56e-05	0.000291	CbGpPWpGaD
Zonisamide—Vomiting—Doxorubicin—peripheral nervous system neoplasm	7.53e-05	0.00014	CcSEcCtD
Zonisamide—SCN11A—Developmental Biology—HRAS—peripheral nervous system neoplasm	7.52e-05	0.000289	CbGpPWpGaD
Zonisamide—Rash—Doxorubicin—peripheral nervous system neoplasm	7.46e-05	0.000139	CcSEcCtD
Zonisamide—SCN3A—Axon guidance—HRAS—peripheral nervous system neoplasm	7.46e-05	0.000287	CbGpPWpGaD
Zonisamide—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	7.46e-05	0.000139	CcSEcCtD
Zonisamide—AOX1—Metabolism—TH—peripheral nervous system neoplasm	7.45e-05	0.000287	CbGpPWpGaD
Zonisamide—Headache—Doxorubicin—peripheral nervous system neoplasm	7.41e-05	0.000138	CcSEcCtD
Zonisamide—SCN3A—Developmental Biology—NRAS—peripheral nervous system neoplasm	7.27e-05	0.00028	CbGpPWpGaD
Zonisamide—CA9—Cellular responses to stress—TP53—peripheral nervous system neoplasm	7.24e-05	0.000278	CbGpPWpGaD
Zonisamide—SCN2A—Axon guidance—HRAS—peripheral nervous system neoplasm	7.16e-05	0.000275	CbGpPWpGaD
Zonisamide—SCN4A—Axon guidance—HRAS—peripheral nervous system neoplasm	7.16e-05	0.000275	CbGpPWpGaD
Zonisamide—CA9—Metabolism—BCHE—peripheral nervous system neoplasm	7.11e-05	0.000273	CbGpPWpGaD
Zonisamide—Nausea—Doxorubicin—peripheral nervous system neoplasm	7.03e-05	0.000131	CcSEcCtD
Zonisamide—CACNA1I—Developmental Biology—AKT1—peripheral nervous system neoplasm	7.01e-05	0.000269	CbGpPWpGaD
Zonisamide—SCN2A—Developmental Biology—NRAS—peripheral nervous system neoplasm	6.99e-05	0.000269	CbGpPWpGaD
Zonisamide—SCN4A—Developmental Biology—NRAS—peripheral nervous system neoplasm	6.99e-05	0.000269	CbGpPWpGaD
Zonisamide—SCN1A—Axon guidance—HRAS—peripheral nervous system neoplasm	6.91e-05	0.000266	CbGpPWpGaD
Zonisamide—CA9—Metabolism—SLC2A1—peripheral nervous system neoplasm	6.78e-05	0.000261	CbGpPWpGaD
Zonisamide—CA4—Metabolism—GNAS—peripheral nervous system neoplasm	6.75e-05	0.00026	CbGpPWpGaD
Zonisamide—SCN1A—Developmental Biology—NRAS—peripheral nervous system neoplasm	6.74e-05	0.000259	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—BCHE—peripheral nervous system neoplasm	6.7e-05	0.000258	CbGpPWpGaD
Zonisamide—CA9—Metabolism—TH—peripheral nervous system neoplasm	6.68e-05	0.000257	CbGpPWpGaD
Zonisamide—SCN11A—Developmental Biology—AKT1—peripheral nervous system neoplasm	6.64e-05	0.000255	CbGpPWpGaD
Zonisamide—SCN5A—Axon guidance—NRAS—peripheral nervous system neoplasm	6.64e-05	0.000255	CbGpPWpGaD
Zonisamide—CA4—Metabolism—ABCB1—peripheral nervous system neoplasm	6.62e-05	0.000255	CbGpPWpGaD
Zonisamide—CA2—Metabolism—GNAS—peripheral nervous system neoplasm	6.47e-05	0.000249	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—SLC2A1—peripheral nervous system neoplasm	6.39e-05	0.000246	CbGpPWpGaD
Zonisamide—CA2—Metabolism—ABCB1—peripheral nervous system neoplasm	6.35e-05	0.000244	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—TH—peripheral nervous system neoplasm	6.3e-05	0.000242	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—ERBB2—peripheral nervous system neoplasm	6.23e-05	0.000239	CbGpPWpGaD
Zonisamide—CA1—Metabolism—GNAS—peripheral nervous system neoplasm	6.2e-05	0.000239	CbGpPWpGaD
Zonisamide—CA1—Metabolism—ABCB1—peripheral nervous system neoplasm	6.09e-05	0.000234	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—GNAS—peripheral nervous system neoplasm	6.08e-05	0.000234	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—ABCB1—peripheral nervous system neoplasm	5.97e-05	0.00023	CbGpPWpGaD
Zonisamide—CACNA1G—Developmental Biology—HRAS—peripheral nervous system neoplasm	5.85e-05	0.000225	CbGpPWpGaD
Zonisamide—CACNA1H—Developmental Biology—HRAS—peripheral nervous system neoplasm	5.66e-05	0.000218	CbGpPWpGaD
Zonisamide—SCN9A—Developmental Biology—HRAS—peripheral nervous system neoplasm	5.56e-05	0.000214	CbGpPWpGaD
Zonisamide—CA9—Metabolism—GNAS—peripheral nervous system neoplasm	5.45e-05	0.00021	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—HSD17B12—peripheral nervous system neoplasm	5.37e-05	0.000207	CbGpPWpGaD
Zonisamide—CA9—Metabolism—ABCB1—peripheral nervous system neoplasm	5.35e-05	0.000206	CbGpPWpGaD
Zonisamide—SCN3A—Developmental Biology—HRAS—peripheral nervous system neoplasm	5.32e-05	0.000205	CbGpPWpGaD
Zonisamide—CACNA1G—Developmental Biology—AKT1—peripheral nervous system neoplasm	5.16e-05	0.000199	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—GNAS—peripheral nervous system neoplasm	5.14e-05	0.000198	CbGpPWpGaD
Zonisamide—SCN2A—Developmental Biology—HRAS—peripheral nervous system neoplasm	5.11e-05	0.000197	CbGpPWpGaD
Zonisamide—SCN4A—Developmental Biology—HRAS—peripheral nervous system neoplasm	5.11e-05	0.000197	CbGpPWpGaD
Zonisamide—MAOA—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	5.11e-05	0.000197	CbGpPWpGaD
Zonisamide—AOX1—Disease—PTPN11—peripheral nervous system neoplasm	5.05e-05	0.000194	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—ABCB1—peripheral nervous system neoplasm	5.04e-05	0.000194	CbGpPWpGaD
Zonisamide—CACNA1H—Developmental Biology—AKT1—peripheral nervous system neoplasm	5e-05	0.000192	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—ENO2—peripheral nervous system neoplasm	4.97e-05	0.000191	CbGpPWpGaD
Zonisamide—SCN1A—Developmental Biology—HRAS—peripheral nervous system neoplasm	4.93e-05	0.00019	CbGpPWpGaD
Zonisamide—SCN9A—Developmental Biology—AKT1—peripheral nervous system neoplasm	4.91e-05	0.000189	CbGpPWpGaD
Zonisamide—SCN5A—Axon guidance—HRAS—peripheral nervous system neoplasm	4.86e-05	0.000187	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—PPIP5K2—peripheral nervous system neoplasm	4.78e-05	0.000184	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—NRAS—peripheral nervous system neoplasm	4.74e-05	0.000182	CbGpPWpGaD
Zonisamide—SCN3A—Developmental Biology—AKT1—peripheral nervous system neoplasm	4.7e-05	0.000181	CbGpPWpGaD
Zonisamide—SCN2A—Developmental Biology—AKT1—peripheral nervous system neoplasm	4.51e-05	0.000174	CbGpPWpGaD
Zonisamide—SCN4A—Developmental Biology—AKT1—peripheral nervous system neoplasm	4.51e-05	0.000174	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	4.47e-05	0.000172	CbGpPWpGaD
Zonisamide—SCN1A—Developmental Biology—AKT1—peripheral nervous system neoplasm	4.35e-05	0.000167	CbGpPWpGaD
Zonisamide—CA3—Metabolism—AKT1—peripheral nervous system neoplasm	4.21e-05	0.000162	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—BCHE—peripheral nervous system neoplasm	4.2e-05	0.000162	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—SLC2A1—peripheral nervous system neoplasm	4.01e-05	0.000154	CbGpPWpGaD
Zonisamide—AOX1—Disease—ERBB2—peripheral nervous system neoplasm	3.99e-05	0.000153	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—TH—peripheral nervous system neoplasm	3.95e-05	0.000152	CbGpPWpGaD
Zonisamide—MAOA—Neuronal System—HRAS—peripheral nervous system neoplasm	3.92e-05	0.000151	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—GNS—peripheral nervous system neoplasm	3.89e-05	0.000149	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—NME1—peripheral nervous system neoplasm	3.73e-05	0.000143	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—COX2—peripheral nervous system neoplasm	3.59e-05	0.000138	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—HRAS—peripheral nervous system neoplasm	3.47e-05	0.000133	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—HSD17B12—peripheral nervous system neoplasm	3.23e-05	0.000124	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—GNAS—peripheral nervous system neoplasm	3.23e-05	0.000124	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—ABCB1—peripheral nervous system neoplasm	3.17e-05	0.000122	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—AKT1—peripheral nervous system neoplasm	3.06e-05	0.000118	CbGpPWpGaD
Zonisamide—AOX1—Disease—NRAS—peripheral nervous system neoplasm	3.04e-05	0.000117	CbGpPWpGaD
Zonisamide—AOX1—Disease—MYC—peripheral nervous system neoplasm	2.83e-05	0.000109	CbGpPWpGaD
Zonisamide—CA14—Metabolism—AKT1—peripheral nervous system neoplasm	2.71e-05	0.000104	CbGpPWpGaD
Zonisamide—CA5A—Metabolism—AKT1—peripheral nervous system neoplasm	2.64e-05	0.000102	CbGpPWpGaD
Zonisamide—CA6—Metabolism—AKT1—peripheral nervous system neoplasm	2.64e-05	0.000102	CbGpPWpGaD
Zonisamide—CA7—Metabolism—AKT1—peripheral nervous system neoplasm	2.47e-05	9.48e-05	CbGpPWpGaD
Zonisamide—CA5B—Metabolism—AKT1—peripheral nervous system neoplasm	2.47e-05	9.48e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—ENO2—peripheral nervous system neoplasm	2.35e-05	9.05e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—GNS—peripheral nervous system neoplasm	2.34e-05	8.99e-05	CbGpPWpGaD
Zonisamide—CA12—Metabolism—AKT1—peripheral nervous system neoplasm	2.28e-05	8.78e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—NME1—peripheral nervous system neoplasm	2.24e-05	8.61e-05	CbGpPWpGaD
Zonisamide—AOX1—Disease—HRAS—peripheral nervous system neoplasm	2.22e-05	8.54e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—COX2—peripheral nervous system neoplasm	2.16e-05	8.29e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—BCHE—peripheral nervous system neoplasm	1.99e-05	7.65e-05	CbGpPWpGaD
Zonisamide—AOX1—Disease—AKT1—peripheral nervous system neoplasm	1.96e-05	7.54e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.9e-05	7.3e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—TH—peripheral nervous system neoplasm	1.87e-05	7.19e-05	CbGpPWpGaD
Zonisamide—CA4—Metabolism—AKT1—peripheral nervous system neoplasm	1.82e-05	7.01e-05	CbGpPWpGaD
Zonisamide—CA2—Metabolism—AKT1—peripheral nervous system neoplasm	1.75e-05	6.72e-05	CbGpPWpGaD
Zonisamide—CA1—Metabolism—AKT1—peripheral nervous system neoplasm	1.67e-05	6.44e-05	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—AKT1—peripheral nervous system neoplasm	1.64e-05	6.31e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—GNAS—peripheral nervous system neoplasm	1.53e-05	5.87e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—ABCB1—peripheral nervous system neoplasm	1.5e-05	5.76e-05	CbGpPWpGaD
Zonisamide—CA9—Metabolism—AKT1—peripheral nervous system neoplasm	1.47e-05	5.66e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—ENO2—peripheral nervous system neoplasm	1.42e-05	5.44e-05	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—AKT1—peripheral nervous system neoplasm	1.39e-05	5.34e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—BCHE—peripheral nervous system neoplasm	1.2e-05	4.6e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.14e-05	4.39e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—TH—peripheral nervous system neoplasm	1.12e-05	4.32e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—GNAS—peripheral nervous system neoplasm	9.18e-06	3.53e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—ABCB1—peripheral nervous system neoplasm	9.01e-06	3.46e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—AKT1—peripheral nervous system neoplasm	8.71e-06	3.35e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—AKT1—peripheral nervous system neoplasm	4.12e-06	1.58e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—AKT1—peripheral nervous system neoplasm	2.48e-06	9.53e-06	CbGpPWpGaD
